Rebuttal comments on “Glucocorticoids in breast cancer treatment: Real benefit or selection bias?”
Journal
Breast Cancer Research and Treatment
Journal Volume
172
Journal Issue
1
Date Issued
2018
Author(s)
Tang C.-H.
SDGs
Other Subjects
anthracycline; glucocorticoid; breast cancer; cancer chemotherapy; cancer classification; cancer survival; cancer therapy; dose response; drug use; human; Letter; overall survival; physician; priority journal; progression free survival; prospective study; selection bias
Publisher
Springer New York LLC
Type
letter